Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis

被引：21
作者：
Cudillo, L
Girmenia, C
Santilli, S
Picardi, A
Dentamaro, T
Tendas, A
de Fabritiis, P
机构：
[1] Univ Roma Tor Vergata, Dept Hematol, Osped S Eugenio, I-00144 Rome, Italy
[2] Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, Rome, Italy
来源：
CLINICAL INFECTIOUS DISEASES | 2005年 / 40卷 / 08期
关键词：
D O I：
10.1086/428849
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1212 / 1213
页数：2
相关论文
共 8 条
[1]   Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole [J].
Bigley, VH ;
Duarte, RF ;
Gosling, RD ;
Kibbler, CC ;
Seaton, S ;
Potter, M .
BONE MARROW TRANSPLANTATION, 2004, 34 (09) :815-817
[2]   Successsful voriconazole treatment of disseminated Fusarium infection in an immunocompromised patient [J].
Consigny, S ;
Dhedin, N ;
Datry, A ;
Choquet, S ;
Leblond, V ;
Chosidow, O .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (02) :311-313
[3]   In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi [J].
Espinel-Ingroff, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (03) :954-958
[4]   Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole [J].
Imhof, A ;
Balajee, SA ;
Fredricks, DN ;
Englund, JA ;
Marr, KA .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (05) :743-746
[5]   Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants [J].
Marty, FM ;
Cosimi, LA ;
Baden, LR .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (09) :950-952
[6]   In vitro activities of investigational triazoles against Fusarium species:: Effects of inoculum size and incubation time on broth microdilution susceptibility test results [J].
Paphitou, NI ;
Ostrosky-Zeichner, L ;
Paetznick, VL ;
Rodriguez, JR ;
Chen, EN ;
Rex, JH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (10) :3298-3300
[7]   Voriconazole treatment for less-common, emerging, or refractory fungal infections [J].
Perfect, JR ;
Marr, KA ;
Walsh, TJ ;
Greenberg, RN ;
DuPont, B ;
de la Torre-Cisneros, J ;
Just-Nübling, G ;
Schlamm, HT ;
Lutsar, I ;
Espinel-Ingroff, A ;
Johnson, E .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (09) :1122-1131
[8]   Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis [J].
Siwek, GT ;
Dodgson, KJ ;
de Magalhaes-Silverman, M ;
Bartelt, LA ;
Kilborn, SB ;
Hoth, PL ;
Diekema, DJ ;
Pfaller, MA .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (04) :584-587
1